SVANCEDE
LIVE

Serial Number

79407122

Owner

Novartis AG

Attorney

Maury M. Tepper, III

Filing Date

Aug 1, 2024

Add to watchlist:

No watchlists yet
View on USPTO

SVANCEDE Trademark

Serial Number: 79407122 • Registration: 7734638

SVANCEDE is a trademark filed by Novartis AG on August 1, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Novartis AG (12 trademarks)

CH-4002 Basel

Entity Type: 03

Trademark Details

Filing Date

August 1, 2024

Registration Date

March 25, 2025

Published for Opposition

February 4, 2025

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma.

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 2, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 16, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 16, 2026 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 24, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 25, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 25, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 4, 2025 NPUB
PUBLISHED FOR OPPOSITION
Feb 4, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 29, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 13, 2025 CNSA
ASSIGNED TO EXAMINER
Jan 6, 2025 DOCK
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Nov 6, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 6, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 6, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 6, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 6, 2024 COAR
APPLICATION FILING RECEIPT MAILED
Oct 24, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 24, 2024 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Oct 22, 2024 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 17, 2024 REPR